![]() |
Todar's Online Textbook of Bacteriology |
Introduction
Microbial pathogenicity has been defined as the structural and biochemical mechanisms whereby microorganisms cause disease. Pathogenicity in bacteria may be associated with unique structural components of the cells (e.g. capsules, fimbriae, LPS or other cell wall components) or active secretion of substances that either damage host tissues or protect the bacteria against host defenses. Hence, there are two broad qualities of pathogenic bacteria that underlie the means by which they cause disease: invasiveness and toxigenesis.
Toxigenesis is the ability to produce toxins. Toxic substances produced by bacteria, both soluble and cell-associated, may be transported by blood and lymph and cause cytotoxic effects at tissue sites remote from the original point of invasion or growth.
Invasiveness is the ability of a pathogen to invade tissues. Invasiveness encompasses (1) mechanisms for colonization (adherence and initial multiplication), (2) production of extracellular substances ("invasins"), that promote the immediate invasion of tissues and (3) ability to bypass or overcome host defense mechanisms which facilitate the actual invasive process. This chapter deals with the first two aspects of of invasiveness: colonization and invasion.
The first stage of microbial infection is colonization: the establishment of the pathogen at the appropriate portal of entry. Pathogens usually colonize host tissues that are in contact with the external environment. Sites of entry in human hosts include the urogenital tract, the digestive tract, the respiratory tract and the conjunctiva. Organisms that infect these regions have usually developed tissue adherence mechanisms and some ability to overcome or withstand the constant pressure of the host defenses at the surface.
Bacterial Adherence to Mucosal Surfaces. In its simplest form, bacterial adherence or attachment to a eucaryotic cell or tissue surface requires the participation of two factors: a receptor and a ligand. The receptors so far defined are usually specific carbohydrate or peptide residues on the eucaryotic cell surface. The bacterial ligand, called an adhesin, is typically a macromolecular component of the bacterial cell surface which interacts with the host cell receptor. Adhesins and receptors usually interact in a complementary and specific fashion with specificity comparable to enzyme-substrate relationships and antigen-antibody reactions. Table 1 is a list of terms that are used in medical microbiology to refer to microbial adherence to surfaces or tissues.| ADHERENCE FACTOR | DESCRIPTION |
|---|---|
| Adhesin | A surface structure or macromolecule that binds a bacterium to a specific surface |
| Receptor | A complementary macromolecular binding site on a (eucaryotic) surface that binds specific adhesins or ligands |
| Lectin | Any protein that binds to a carbohydrate |
| Ligand | A surface molecule that exhibits specific binding to a receptor molecule on another surface |
| Mucous | The mucopolysaccharide layer of glucosaminoglycans covering animal cell mucosal surfaces |
| Fimbriae | Filamentous proteins on the surface of bacterial cells that may behave as adhesins for specific adherence |
| Common pili | Same as fimbriae |
| Sex pilus | A specialized pilus that binds mating procaryotes together for the purpose of DNA transfer |
| Type 1 fimbriae | Fimbriae in Enterobacteriaceae which bind specifically to mannose terminated glycoproteins on eucaryotic cell surfaces |
| Type 4 pili |
Pili in certain Gram-positive
and Gram-negative bacteria. In Pseudomonas,
thought to play a role in adherence and biofilm formation |
| Biofilm |
exopolysaccharide or slime
produced by bacteria that attaches imbedded cells to a surface |
S-layer |
Proteins that form the outermost cell envelope component of a broad spectrum of bacteria, enabling them to adhere to host cell membranes and environmental surfaces in order to colonize. |
| Glycocalyx | A layer of exopolysaccharide fibers on the surface of
bacterial cells
which may be involved in adherence to a surface. Sometimes a general
term for a bacterial capsules. |
| Capsule | A detectable layer of polysaccharide (rarely polypeptide) on the surface of a bacterial cell which may mediate specific or nonspecific attachment |
| Lipopolysaccharide (LPS) | A distinct cell wall component of the outer membrane of Gram-negative bacteria with the potential structural diversity to mediate specific adherence. Probably functions as an adhesin |
| Teichoic acids and lipoteichoic acids (LTA) | Cell wall components of Gram-positive bacteria that may be involved in nonspecific or specific adherence |
Specific Adherence of Bacteria to Cell and Tissue Surfaces
Several types of observations have provided indirect evidence for specificity of adherence of bacteria to host cells or tissues:
1. Tissue tropism. Particular bacteria are known to have an
apparent
preference for certain tissues over others, e.g. S. mutans is
abundant
in dental plaque but does not occur on epithelial surfaces of the
tongue;
the reverse is true for S. salivarius which is attached in high
numbers to epithelial cells of the tongue but is absent in dental
plaque. Corynebacterium diphtheriae
colonizes exclusively in the throat.
2. Species specificity. Certain pathogenic bacteria infect
only
certain species of animals, e.g. N. gonorrhoeae and Bordetella pertussis infections are
limited
to humans; enteropathogenic E. coli K-88 infections are limited
to pigs; E. coli CFA I and CFA II infect humans; E. coli
K-99
strains infect calves.; Group A streptococcal infections occur only in
humans. In addition, certain indigenous species and symbionts are quite
specific in their associations with specific animal hosts.
3. Genetic specificity within a species: certain strains or
races
within a species may be genetically immune to a pathogen, e.g. certain
pigs
are not susceptible to E. coli K-88 infections; males are not
susceptible to mastitis; females are not susceptible to orchitis; A
percentage of females are not susceptible to urinary tract infection
(UTI) caused by E. coli.
Although other explanations are possible, the above observations might be explained by the existence of specific interactions between microorganisms and eucaryotic tissue surfaces which allow microorganisms to become established on the surface.
Mechanisms of Adherence to Cell or Tissue Surfaces
The mechanisms for adherence may involve two steps:
1. nonspecific adherence: reversible attachment of the bacterium to the eucaryotic surface (sometimes called "docking")
2. specific adherence: irreversible permanent attachment of the microorganism to the surface (sometimes called "anchoring").
The usual situation is that reversible attachment precedes irreversible attachment but in some cases, the opposite situation occurs or specific adherence may never occur.
Nonspecific adherence involves nonspecific attractive forces which allow approach of the bacterium to the eucaryotic cell surface. Possible interactions and forces involved are:
1. hydrophobic interactions
2. electrostatic attractions
3. atomic and molecular vibrations resulting from fluctuating dipoles of similar frequencies
4. Brownian movement
5. recruitment and trapping by biofilm polymers interacting with the bacterial glycocalyx (capsule)
Specific adherence involves
permanent
formation of many specific lock-and-key bonds between complementary
molecules
on each cell surface. Complementary receptor and adhesin molecules must
be accessible and arranged in such a way that many bonds form over the
area of contact between the two cells. Once the bonds are formed,
attachment
under physiological conditions becomes virtually irreversible.

Several types of experiments provide direct evidence that receptor and/or adhesin molecules mediate specificity of adherence of bacteria to host cells or tissues. These include:
1. The bacteria will bind isolated receptors or receptor analogs.
2. The isolated adhesins or adhesin analogs will bind to the eucaryotic cell surface.
3. Adhesion (of the bacterium to the eucaryotic cell surface) is inhibited by:
b. adhesin or receptor analogs
c. enzymes and chemicals that specifically destroy adhesins or receptors
d. antibodies specific to surface components (i.e., adhesins or receptors)Type-I fimbriae enable E. coli to bind to D-mannose residues on eucaryotic cell surfaces. Type-I fimbriae are said to be "mannose-sensitive" since exogenous mannose blocks binding to receptors on red blood cells. Although the primary 17kDa fimbrial subunit is the major protein component of Type-1 fimbriae, the mannose-binding site is not located here, but resides in a minor protein (28-31kDa) located at the tips or inserted along the length of the fimbriae. By genetically varying the minor "tip protein" adhesin, the organisms can gain ability to adhere to different receptors. For example, tip proteins on pyelonephritis-associated (pap) pili recognize a galactose-galactose disaccharide, while tip proteins on S-fimbriae recognize sialic acid. S fimbriae are able to recognize receptor molecules containing sialic acid and are produced by pathogenic E. coli strains causing urinary tract infection.
Pseudomonas, Vibrio and Neisseria
possess Type IV pili that contain a protein subunit with a methylated
amino acid, often
phenylalanine,
at or near its amino terminus. These "N-methylphenylalanine pili" have
been
established
as virulence determinants in pathogenesis of Pseudomonas aeruginosa
lung infection in cystic fibrosis patients. These type of fimbriae
occur
in Neisseria gonorrhoeae and their receptor is thought to be an
oligosaccharide. Type IV pili are the tcp (toxin coregulated pili)
fimbriae used in attachment of Vibrio
cholerae to the gastrointestinal
epithelium.

The adhesins of Streptococcus pyogenes are
controversial.
In 1972, Gibbons and his colleagues demonstrated that attachment of
streptococci
to the oral mucosa of mice is dependent on M protein. Olfek and Beachey
argued that lipoteichoic acid (LTA), rather than M protein, was
responsible
for streptococcal adherence to buccal epithelial cells. In 1996, Hasty
and Courtney proposed a two-step model of attachment that involved both
M protein and teichoic acids. They suggested that LTA loosely
tethers
streptococci to epithelial cells, and then M protein secures a firmer,
irreversible association. In 1992, protein F was
discovered and found to be a fibronectin binding protein. More
recently,
in 1998, M proteins M1 and M3 were also found to bind to fibronectin.
Apparently,
S.
pyogenes produces multiple adhesins with varied specificities.
Electron micrograph of Streptococcus pyogenes (Group A streptococci) by Maria Fazio and Vincent A.
Fischetti,
Ph.D. with permission. The
Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller
University.
The cell surface
fibrils, that consist primarily of M protein, are clearly
evident. The M protein has several possible roles in virulence:
it is involved in adherence, resistance to phagocytosis, and in
antigenic variation of the pathogen.
Staphylococcus aureus also binds to the amino terminus of fibronectin by means of a fibronectin-binding protein which occurs on the bacterial surface. Apparently, S. aureus and Group A streptococci use different mechanisms but adhere to the same receptor on epithelial surfaces.
Treponema pallidum has three related surface adhesins
(P1, P2 and P3), which bind to a four-amino acid sequence
(Arg-Gly-Asp-Ser)
of the cell-binding domain of fibronectin. It is not clear if T.
pallidum
uses fibronectin to attach to host surfaces or coats itself with
fibronectin
to avoid host defenses (phagocytes and immune responses).

| Bacterium | Adhesin | Receptor | Attachment site | Disease |
| Streptococcus pyogenes | Protein F | Amino terminus of fibronectin | Pharyngeal epithelium | Sore throat |
| Streptococcus mutans | Glycosyl transferase | Salivary glycoprotein | Pellicle of tooth | Dental caries |
| Streptococcus salivarius | Lipoteichoic acid | Unknown | Buccal epithelium of tongue | None |
| Streptococcus pneumoniae | Cell-bound protein | N-acetylhexosamine-galactose disaccharide | Mucosal epithelium | pneumonia |
| Staphylococcus aureus | Cell-bound protein | Amino terminus of fibronectin | Mucosal epithelium | Various |
| Neisseria gonorrhoeae | Type IV pili (N-methylphenyl- alanine pili) | Glucosamine-galactose carbohydrate | Urethral/cervical epithelium | Gonorrhea |
| Enterotoxigenic E. coli | Type-I fimbriae | Species-specific carbohydrate(s) | Intestinal epithelium | Diarrhea |
| Uropathogenic E. coli | Type I fimbriae | Complex carbohydrate | Urethral epithelium | Urethritis |
| Uropathogenic E. coli | P-pili (pap) | Globobiose linked to ceramide lipid | Upper urinary tract | Pyelonephritis |
| Bordetella pertussis | Fimbriae ("filamentous hemagglutinin") | Galactose on sulfated glycolipids | Respiratory epithelium | Whooping cough |
| Vibrio cholerae | N-methylphenylalanine pili | Fucose and mannose carbohydrate | Intestinal epithelium | Cholera |
| Treponema pallidum | Peptide in outer membrane | Surface protein (fibronectin) | Mucosal epithelium | Syphilis |
| Mycoplasma | Membrane protein | Sialic acid | Respiratory epithelium | Pneumonia |
| Chlamydia | Unknown | Sialic acid | Conjunctival or urethral epithelium | Conjunctivitis or urethritis |
The invasion of a host by a pathogen may be aided by the production of bacterial extracellular substances which act against the host by breaking down primary or secondary defenses of the body. Medical microbiologists refer to these substances as invasins. Most invasins are proteins (enzymes) that act locally to damage host cells and/or have the immediate effect of facilitating the growth and spread of the pathogen. The damage to the host as a result of this invasive activity may become part of the pathology of an infectious disease.
The extracellular proteins produced by bacteria which promote their invasion are not clearly distinguished from some extracellular protein toxins ("exotoxins") which also damage the host. Invasins usually act at a short range (in the immediate vicinity of bacterial growth) and may not actually kill cells as part of their range of activity; exotoxins are often cytotoxic and may act at remote sites (removed from the site of bacterial growth). Also, exotoxins typically are more specific and more potent in their activity than invasins. Even so, some classic exotoxins (e.g. diphtheria toxin, anthrax toxin) may play some role in colonization or invasion in the early stages of an infection, and some invasins (e.g. staphylococcal leukocidin) have a relatively specific cytopathic effect.
A Survey of Bacterial Invasins
Hyaluronidase. is the original spreading factor. It is produced by streptococci. staphylococci, and clostridia. The enzyme attacks the interstitial cement ("ground substance") of connective tissue by depolymerizing hyaluronic acid.
Collagenase is produced by Clostridium histolyticum and Clostridium perfringens. It breaks down collagen, the framework of muscles, which facilitates gas gangrene due to these organisms.
Neuraminidase is produced by intestinal pathogens such as Vibrio cholerae and Shigella dysenteriae. It degrades neuraminic acid (also called sialic acid), an intercellular cement of the epithelial cells of the intestinal mucosa.
Streptokinase and staphylokinase are produced by streptococci and staphylococci, respectively. Kinase enzymes convert inactive plasminogen to plasmin which digests fibrin and prevents clotting of the blood. The relative absence of fibrin in spreading bacterial lesions allows more rapid diffusion of the infectious bacteria.
Enzymes that Cause Hemolysis and/or Leucolysis
These enzymes usually act on the animal cell membrane by insertion into the membrane (forming a pore that results in cell lysis), or by enzymatic attack on phospholipids, which destabilizes the membrane. They may act as lecithinases or phospholipases, and if they lyse red blood cells they are sometimes called hemolysins. Leukocidins, produced by staphylococci and streptolysin produced by streptococci specifically lyse phagocytes and their granules. These latter two enzymes are also considered to be bacterial exotoxins.
Phospholipases, produced by Clostridium perfringens (i.e., alpha toxin), hydrolyze phospholipids in cell membranes by removal of polar head groups.
Lecithinases, also produced by Clostridium perfringens, destroy lecithin (phosphatidylcholine) in cell membranes.
Hemolysins, notably produced by staphylococci (i.e.,
alpha
toxin), streptococci (i.e., streptolysin) and various clostridia, may
be
channel-forming proteins or phospholipases or lecithinases that destroy
red blood cells and other cells (i.e., phagocytes) by lysis.

Beta-hemolytic Streptococcus. This is the characteristic appearance of
a blood agar plate culture of the bacterium. Note the translucency
around the bacterial colonies, representing hemolysis of the red cells
in the culture medium due to production of a diffusible hemolysin
(streptolysin).
Staphylococcal coagulase
Coagulase, formed by Staphylococcus aureus, is a cell-associated and diffusible enzyme that converts fibrinogen to fibrin which causes clotting. Coagulase activity is almost always associated with pathogenic S. aureus and almost never associated with nonpathogenic S. epidermidis, which has led to much speculation as to its role as a determinant of virulence. Possibly, cell bound coagulase could provide an antigenic disguise if it clotted fibrin on the cell surface. Or a staphylococcal lesion encased in fibrin (e.g. a boil or pimple) could make the bacterial cells resistant to phagocytes or tissue bactericides or even drugs which might be unable to diffuse to their bacterial target.
Extracellular Digestive Enzymes
Heterotrophic bacteria, in general, produce a wide variety of extracellular enzymes including proteases, lipases, glycohydrolases, nucleases, etc., which are not clearly shown to have a direct role in invasion or pathogenesis. These enzymes presumably have other functions related to bacterial nutrition or metabolism, but may aid in invasion either directly or indirectly.
Toxins With Short-Range Effects Related to Invasion
Bacterial protein toxins which have adenylate cyclase activity are
thought to have immediate effects on host cells that promote bacterial
invasion. One component of the anthrax toxin (EF or Edema
Factor)
is an adenylate cyclase that acts on nearby cells to cause
increased
levels of cyclic AMP and disruption of cell permeability. One of the
toxins
of Bordetella pertussis, the agent of whooping cough, has
a similar effect. These toxins may contribute to invasion through their
effects on macrophages or lymphocytes in the vicinity which are
playing
an essential role to contain the infection. For example, since they use
ATP as a substrate, they may deplete phagocyte reserves of energy
needed for ingestion. Edema is seen as a pathology because the increase
in cAMP in affected cells disrupts equilibrium.

Gelatinous edema seen
in a cutaneous
anthrax lesion. CDC.
The following table summarizes the activities of many bacterial
proteins
that are noted for their contribution to bacterial invasion of tissues.
Invasin |
Bacteria Involved |
Activity |
| Hyaluronidase | Streptococci, staphylococci and clostridia | Degrades hyaluronic of connective tissue |
| Collagenase | Clostridium species | Dissolves collagen framework of muscles |
| Neuraminidase | Vibrio cholerae and Shigella dysenteriae | Degrades neuraminic acid of intestinal mucosa |
| Coagulase | Staphylococcus aureus | Converts fibrinogen to fibrin which causes clotting |
| Kinases | Staphylococci and streptococci | Converts plasminogen to plasmin which digests fibrin |
| Leukocidin | Staphylococcus aureus | Disrupts neutrophil membranes and causes discharge of lysosomal granules |
| Streptolysin | Streptococcus pyogenes | Repels phagocytes and disrupts phagocyte membrane and causes discharge of lysosomal granules |
| Hemolysins | Streptococci, staphylococci and clostridia | Phospholipases or lecithinases that destroy red blood cells (and other cells) by lysis |
| Lecithinases | Clostridium perfringens | Destroy lecithin in cell membranes |
| Phospholipases | Clostridium perfringens | Destroy phospholipids in cell membrane |
| Anthrax EF | Bacillus anthracis | One component (EF) is an adenylate cyclase which causes increased levels of intracellular cyclic AMP |
| Pertussis AC | Bordetella pertussis | One toxin component is an adenylate cyclase that acts locally producing an increase in intracellular cyclic AMP |
Return to Todar's Online Textbook of Bacteriology
Written and edited by Kenneth Todar University of Wisconsin-Madison Department of Bacteriology All rights reserved